FIELD: medicine; diagnostics. SUBSTANCE: chemoluminescence of whole undiluted blood is determined in dynamics before and during treatment. In this case, chemoluminescence kinetics is recorded only in presence of luminol or other luminescent probe without activators of neutrophil oxidizing outburst which simplifies sample preparation procedure. Luminescent probe is added to whole undiluted blood in concentrations of 10-5-10-3M. EFFECT: prompt and quantitative determination of necessity to continue treatment of disease. 2 dwg, 2 ex
Authors
Dates
1999-03-20—Published
1996-11-28—Filed